Atlas Trials

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease

Clinical trial NCT06964269 · RECRUITING

Trial details

NCT number
NCT06964269
Sponsor
Toyos Clinic
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Autoimmune DiseasesDry EyeNeurotrophic Keratitis
Start date
2025-02-11
Primary completion
2028-02-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.